Institute of Health and Society, 21 Claremont Place, Newcastle University, Newcastle upon Tyne, NE2 4AA, UK.
Expert Rev Pharmacoecon Outcomes Res. 2008 Dec;8(6):575-82. doi: 10.1586/14737167.8.6.575.
This paper is focused on establishing why a willingness-to-pay per quality-adjusted life-year value is needed and how such a value can be used in healthcare decision-making. Studies that have estimated willingness-to-pay per quality-adjusted life-year values from stated preference data are reviewed and categorized into three groups. These studies are then compared within and between groups highlighting the limitations of existing studies and their suitability for use in policy-making. The future of such work will be discussed, noting key issues for consideration and debate.
本文旨在探讨为什么需要每质量调整生命年支付意愿价值，以及如何在医疗保健决策中使用这种价值。本文回顾了从陈述偏好数据估计每质量调整生命年支付意愿价值的研究，并将其分为三组。然后，在组内和组间对这些研究进行比较，突出现有研究的局限性及其在决策中的适用性。本文还讨论了此类工作的未来，指出了需要考虑和讨论的关键问题。
